Monika Rosen
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Pharmacokinetics and safety of eptinezumab in children and adolescents with migraine.
Journal: Headache
Published: October 31, 2024
Population pharmacokinetics of eptinezumab in paediatric patients with migraine and dose selection for phase 3 paediatric migraine studies.
Journal: Basic & clinical pharmacology & toxicology
Published: April 23, 2024
Vortioxetine in children and adolescents with major depressive disorder: 6-month and 18-month open-label, flexible-dose, long-term extension studies.
Journal: European child & adolescent psychiatry
Published: October 03, 2023
Vortioxetine for Major Depressive Disorder in Adolescents: 12-Week Randomized, Placebo-Controlled, Fluoxetine-Referenced, Fixed-Dose Study.
Journal: Journal of the American Academy of Child and Adolescent Psychiatry
Published: December 14, 2020
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam Compared with Betamethasone 17-Valerate-Medicated Plaster for the Treatment of Psoriasis.
Journal: Clinical drug investigation
Published: December 21, 2016
Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam is Effective, Independent of Body Mass Index and the Extent and Severity of Psoriasis.
Journal: Dermatology and therapy
Published: August 23, 2016
Aerosol Foam Formulation of Fixed Combination Calcipotriene Plus Betamethasone Dipropionate is Highly Efficacious in Patients With Psoriasis Vulgaris: Pooled Data From Three Randomized Controlled Studies.
Journal: Journal of drugs in dermatology : JDD
Published: August 19, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026